Abiopharma

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Disclosure of Interest / Changes in Interest of Substantial Shareholder

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest / Changes in Interest of Director / Chief Executive Officer

Register of shareholders, changes and capital status – exercise of non-tradable warrants

Q1 2026 report - iXBRL report

Yiren Digital to Report First Quarter 2026 Financial Results on June 25, 2026

Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against Gildan Activewear Inc.

FinVolution Group Publishes Eighth Annual ESG Report

Register of shareholders, changes and share capital status – issuance of shares as a result of exercising employee warrants

Forrester Opens Nominations For Its 2026 B2B Awards In EMEA

Director/PDMR Shareholding